NCT03523403
- Conditions
- Body Weight, Dysbiosis, Dyslipidemias, +13 more
- Locations
-
- Human Nutraceutical Research Unit, University of Guelph Guelph, Ontario, Canada
Clinical trial condition
Lipid Metabolism Disorders
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
3,311 public trials
329 recruiting studies
Lipid Metabolism Disorders trial results
NCT02742545
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Cardiovascular Diseases, +10 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT02312492
- Conditions
- Dyslipidemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States
NCT01358474
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +21 more
- Locations
-
- University of Minnesota, Center for Magnetic Resonance Research Minneapolis, Minnesota, United States
NCT03917212
- Conditions
- Digestive System Diseases, Dyslipidemias, Energy Metabolism, +9 more
- Locations
-
- Department of General Pediatrics, Neonatology and Pediatric Cardiology of the University Children's Hospital Düsseldorf Düsseldorf, North Rhine-Westphalia, Germany
- Institute for Clinical Diabetology, German Diabetes Center Düsseldorf, North Rhine-Westphalia, Germany
Completed
A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol
NCT01426412
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Glendale, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madison, Wisconsin, United States
NCT01607294
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +8 more
- Locations
-
- Miramar, Florida, United States
NCT01779453
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Indianapolis, Indiana, United States
- Louisville, Kentucky, United States
- Richmond, Virginia, United States
Completed
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
NCT02659397
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemia, +4 more
- Locations
-
- Anaheim, California, United States
- Los Angeles, California, United States
- Northridge, California, United States
- Clearwater, Florida, United States
NCT02072161
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Muscle Shoals, Alabama, United States
- Chandler, Arizona, United States
- Chino, California, United States
- Los Angeles, California, United States